BAM
Blueshift Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,398
| Closed | -$208K | – | 665 |
|
|
2022
Q2 | $208K | Sell |
4,398
-480
| -10% | -$22.7K | 0.03% | 569 |
|
|
2022
Q1 | $347K | Buy |
+4,878
| New | +$347K | 0.03% | 565 |
|
|
2019
Q3 | – | Sell |
-3,205
| Closed | -$270K | – | 785 |
|
|
2019
Q2 | $270K | Buy |
3,205
+582
| +22% | +$49K | 0.04% | 573 |
|
|
2019
Q1 | $251K | Buy |
+2,623
| New | +$251K | 0.04% | 573 |
|